Open original FDA record ↗Recall record
- FDA identifier
- Z-0499-2020
- Company in FDA record
- Becton Dickinson & Company
- FDA record creation date
- Nov 20, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.
Source facts
- Action
- BD issued notifications to Customers via FedEx to Distributors, Pharmacies, and Consumers via Pharmacies on 10/14/19, advising of the problem, health risk and action to take: Immediately review your inventory for the specific Catalog and Lot number listed , discontinue use and destroy all product subject to the recall following your institutions process for destruction.2. Complete the Customer Recall Response Form. Questions or require further assistance, please contact 1-888-731-7973 between 8 AM and 5 PM ET Monday through Friday.
- Initiated
- 2019-10-14
- Root cause
- Packaging process control
- Terminated
- 2020-10-16
- Distribution
- Distribution US Nationwide and Canada
- Recall number
- Z-0499-2020
- Recall status
- Terminated
- CDRH record ID
- 177219
- FDA record created
- 2019-11-20
- Recall event number
- 84113